Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06532149
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-29
Brief Title:
ERectile Dysfunctions gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
ERectile Dysfunctions gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer EROS
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EROS
Brief Summary:
Although many phase III clinical trials evaluate the quality of life as a secondary endpoint male sexuality remains a neglected topic in oncology research In light of the long-term efficacy of new-generation anticancer treatments for ANSCLC ie targeted therapies and immunotherapy there is a paucity of data about any detrimental effect on fertility and sexuality that could complicate the therapy proposal especially in young patients
The aim of this trial is to assess incidence of endocrine toxicity and sexual dysfuction in male patients receiving active treatment for ANSCLC
The aim of this trial is to assess incidence of endocrine toxicity and sexual dysfuction in male patients receiving active treatment for ANSCLC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None